"This center offers heart care ranging from cardiology to heart surgery and care for vascular diseases (circulation) are all provided at the center. There are both inpatient and outpatient services—hospital and clinic services."

During the past decade, University of Utah Cardiovascular Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Utah Cardiovascular Center" are "Chronic Thromboembolic Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "University of Utah Cardiovascular Center" in a lesser frequency.

Most popular intervention types in "University of Utah Cardiovascular Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan" (1 trials) and "Selexipag" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah Cardiovascular Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Utah Cardiovascular Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Utah Cardiovascular Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah Cardiovascular Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".